Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

997
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
997
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

864
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
864
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

8.3K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
8.3K
Focusing of Light in the Eye01:16

Focusing of Light in the Eye

4.7K
Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
4.7K
Anatomy of the Eyeball01:20

Anatomy of the Eyeball

9.1K
The eye is a spherical, hollow structure composed of three tissue layers. The outer layer — the fibrous tunic, comprises the sclera — a white structure — and the cornea, which is transparent. The sclera encompasses some of the ocular surface, most of which is not visible. However, the 'white of the eye' is distinctively visible in humans compared to other species. The cornea, a clear covering at the front of the eye, enables light penetration. The eye's middle...
9.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An evaluation of the use of ChatGPT in production of cataract surgery patient information leaflets by doctors and patients.

European journal of ophthalmology·2026
Same author

Long-Term Safety and Outcomes of β-radiation for Trabeculectomy.

Journal of glaucoma·2022
Same author

Infographic of the UK Glaucoma Treatment Study (UKGTS).

Eye (London, England)·2021
Same author

Infographic: Advanced Glaucoma Intervention Study (AGIS).

Eye (London, England)·2021
Same author

The cost and quality of life impact of glaucoma in Tanzania: An observational study.

PloS one·2020
Same author

Initial experience in self-monitoring of intraocular pressure.

European journal of ophthalmology·2020
Same journal

Vaginal mucosa as an alternative eye-covering tissue in modified osteo-odonto-keratoprosthesis.

Eye (London, England)·2026
Same journal

Prevalence of and risk factors for diabetic retinopathy: The Thessaloniki Eye Study.

Eye (London, England)·2026
Same journal

Eyelid margin tick masquerading as a naevus in a child.

Eye (London, England)·2026
Same journal

Full-thickness macular penetration by welding laser injury.

Eye (London, England)·2026
Same journal

Incidence and characteristics of newly formed polypoidal lesions in polypoidal choroidal vasculopathy.

Eye (London, England)·2026
Same journal

Traumatic intravitreal egg-shaped hematoma.

Eye (London, England)·2026
See all related articles

Related Experiment Video

Updated: Dec 10, 2025

Measuring the Behavioral Effects of Intraocular Scatter
05:10

Measuring the Behavioral Effects of Intraocular Scatter

Published on: February 18, 2021

3.7K

Glaucoma and glare.

Mehran Hamedani1, Barbara Dulley2, Ian Murdoch2

  • 1UCL Institute of Ophthalmology, London, UK. tedhamedani@ymail.com.

Eye (London, England)
|September 3, 2020
PubMed
Summary
This summary is machine-generated.

A new glare tester and questions better assess glaucoma patients' glare disability. Glaucoma severity correlates with worse glare, and subjective and objective measures show increasing variability with symptom severity.

More Related Videos

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.5K
Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
08:55

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

3.4K

Related Experiment Videos

Last Updated: Dec 10, 2025

Measuring the Behavioral Effects of Intraocular Scatter
05:10

Measuring the Behavioral Effects of Intraocular Scatter

Published on: February 18, 2021

3.7K
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.5K
Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
08:55

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

3.4K

Area of Science:

  • Ophthalmology
  • Visual Science
  • Glaucoma Research

Background:

  • Glaucoma significantly impacts visual function.
  • Assessing glare disability in glaucoma patients is crucial for understanding their visual experience.
  • Current methods like visual acuity and visual fields may not fully capture glare-related visual impairment.

Purpose of the Study:

  • To evaluate a novel glare tester and specific questions for assessing glare and visual disability in glaucoma patients.
  • To compare the effectiveness of this new method against traditional visual acuity and visual field tests.
  • To determine if the new approach provides a better measure of patient-reported glare experiences.

Main Methods:

  • A cohort of glaucoma patients underwent assessment using a Brightness Acuity Tester with a glare source.
  • Patients completed the VFQ-25 questionnaire along with four additional glare-specific questions.
  • Objective disability glare (visual acuity reduction due to glare) was compared with subjective glare symptoms using Bland-Altman plots.
  • Data were analyzed based on glaucoma severity and presence of media opacities.

Main Results:

  • Patients with advanced-severe glaucoma exhibited significantly worse disability glare compared to those with mild-moderate glaucoma.
  • Visual acuity reduction due to glare was comparable in magnitude to that caused by media opacities.
  • A trend indicated greater disability glare in more symptomatic patients.
  • Agreement between subjective and objective glare measurements was good for mild symptoms but decreased as symptoms or signs worsened.

Conclusions:

  • Glaucoma is linked to both objective and subjective reductions in visual acuity under glare conditions.
  • Disability glare increases with glaucoma severity.
  • The variability between objective and subjective glare assessments increases with the severity of glare symptoms or signs.